Oxford BioMedica PLC | Mutual Funds
Mutual Funds that own Oxford BioMedica PLC
M&G Investment Funds (3) OEIC - Recovery Fund
11,156,680
16.97%
423,502
3.5%
03/29/2018
Marlborough Special Situations Fund
2,927,877
4.45%
1,227,271
1.58%
03/29/2018
Tredje AP Fonden
1,409,573
2.14%
-105,000
0.04%
06/30/2017
Alliance Trust Sustainable Future ICVC - UK Growth Fund
637,034
0.97%
0
1.67%
05/31/2018
City Financial - UK Opportunities Fund
460,000
0.7%
260,000
3.22%
02/28/2018
BlackRock CIF - UK Equity Tracker Fund
205,894
0.31%
0
0.02%
01/31/2018
Vanguard Invt. Fds. ICVC - FTSE UK All Share Index Unit Trust
176,573
0.27%
0
0.02%
06/30/2018
Aviva Investors Investment Funds ICVC - European Equity Fund
170,202
0.26%
-50,122
0.77%
10/15/2017
SWIP Tracker & Specialist ICVC - UK All Share Tracker
169,434
0.26%
-2,244
0.03%
09/30/2017
Legal & General UK Index Trust
125,793
0.19%
0
0.02%
07/31/2018
| Address |
Windrush Court
Oxford Oxfordshire OX4 6LT
United Kingdom
|
|
Employees
|
- |
| Website |
http://oxfordbiomedica.co.uk |
| Updated |
07/08/2019 |
| Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. It operates through the Platform and Product segment. |
